Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
111M
-
Number of holders
-
284
-
Total 13F shares, excl. options
-
78.1M
-
Shares change
-
+668K
-
Total reported value, excl. options
-
$5.87B
-
Value change
-
+$31.1M
-
Put/Call ratio
-
0.97
-
Number of buys
-
152
-
Number of sells
-
-138
-
Price
-
$75.08
Significant Holders of NovoCure Ltd - Common Stock (NVCR) as of Q4 2021
379 filings reported holding NVCR - NovoCure Ltd - Common Stock as of Q4 2021.
NovoCure Ltd - Common Stock (NVCR) has 284 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 78.1M shares
of 111M outstanding shares and own 70.3% of the company stock.
Largest 10 shareholders include Capital World Investors (12.6M shares), Capital International Investors (11.3M shares), BAILLIE GIFFORD & CO (9.62M shares), VANGUARD GROUP INC (7.89M shares), FMR LLC (7.8M shares), BlackRock Inc. (6.69M shares), STATE STREET CORP (2.49M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.49M shares), CREDIT SUISSE AG/ (1.36M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.28M shares).
This table shows the top 284 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.